Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Richards

Showing results (631-640 of 644) with videos related to

Pageof 65
Sort By:
European Heart Journal. Acute Cardiovascular Care|April 12, 2025
Machine learning to optimise use of natriuretic peptides in the diagnosis of acute heart failureDimitrios Doudesis, Kuan Ken Lee, Mohamed Anwar, et al.
European Journal of Heart Failure|March 25, 2022
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyArantxa González, A Mark Richards, Rudolf A de Boer, et al.
BMJ (Clinical Research Ed.)|June 13, 2022
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling studyKuan Ken Lee, Dimitrios Doudesis, Mohamed Anwar, et al.
JACC. Asia|March 21, 2026
Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based StudyGrace Cao, Nicholas Weight, Silingga Metta Jauhari, et al.
European Journal of Heart Failure|April 30, 2022
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyAlberto Aimo, Giuseppe Vergaro, Arantxa González, et al.
Circulation|November 16, 2017
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical PathwayMartin P Than, John W Pickering, Jeremy M Dryden, et al.
Frontiers in Physiology|July 11, 2022
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-AnalysisTessa Schillemans, Vinicius Tragante, Buamina Maitusong, et al.
Journal of the American College of Cardiology|January 29, 2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysisKenneth Chan, Riyaz S Patel, Paul Newcombe, et al.
The Lancet Regional Health. Western Pacific|August 5, 2024
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regionsRachel Sze Jen Goh, Bryan Chong, Jayanth Jayabaskaran, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
Pageof 65

Showing results (631-640 of 644) with videos related to

Sort By:
Pageof 65
European Heart Journal. Acute Cardiovascular Care|April 12, 2025
Machine learning to optimise use of natriuretic peptides in the diagnosis of acute heart failureDimitrios Doudesis, Kuan Ken Lee, Mohamed Anwar, et al.
European Journal of Heart Failure|March 25, 2022
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyArantxa González, A Mark Richards, Rudolf A de Boer, et al.
BMJ (Clinical Research Ed.)|June 13, 2022
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling studyKuan Ken Lee, Dimitrios Doudesis, Mohamed Anwar, et al.
JACC. Asia|March 21, 2026
Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based StudyGrace Cao, Nicholas Weight, Silingga Metta Jauhari, et al.
European Journal of Heart Failure|April 30, 2022
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyAlberto Aimo, Giuseppe Vergaro, Arantxa González, et al.
Circulation|November 16, 2017
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical PathwayMartin P Than, John W Pickering, Jeremy M Dryden, et al.
Frontiers in Physiology|July 11, 2022
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-AnalysisTessa Schillemans, Vinicius Tragante, Buamina Maitusong, et al.
Journal of the American College of Cardiology|January 29, 2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysisKenneth Chan, Riyaz S Patel, Paul Newcombe, et al.
The Lancet Regional Health. Western Pacific|August 5, 2024
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regionsRachel Sze Jen Goh, Bryan Chong, Jayanth Jayabaskaran, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
Pageof 65